I didn’t choose cancer, cancer chose me. It chooses you too, whether you are among the hundred thousand of us already diagnosed or among the millions who love us. Not everyone gets the chance to help themselves, and in so doing, help a million and more who live in the community affected by neuroendocrine cancers. You have that opportunity. You know that this is a little known cancer; hence, resources to cure it are scarce. In just a short period of time, the Foundation has recently funded significant breakthroughs by working with brilliant researchers who are more driven to make a difference than to make a headline.
Carol Branaman, Board Chair
As a practicing medical oncologist, I have the privilege of caring for people with NETs. As a clinical researcher who conducts trials, I can contribute to incremental improvements in NET treatment. However, as a volunteer for the Neuroendocrine Tumor Research Foundation and co-chair of their Scientific Advisory Board, I can direct grants to the laboratory scientists poised to crack the NET code, recruit the best and brightest of our young scientists to ensure the future of NET research and fund the most innovative and transformative science to impact the future care of all NET patients.
George Fisher, Board of Scientific Advisors Co-Chair
I support this exceptional foundation because it is a beacon of light in the dark, turbulent sea neuroendocrine patients find themselves adrift in once being diagnosed. For me having known that these wonderful people are working tirelessly to find a cure for my cancer brings me much hope for a cancer free future.
Dave McCoy, NET Research Foundation Supporter
I am honored, excited, and stimulated to serve on the [Board of Scientific Advisors] BOSA. The group represents academia, non-profit foundations, biotech and pharma research, and is dedicated to funding, through a peer-review process, promising and impactful NET research.
Evan Vosburgh, Board of Scientific Advisors
After nearly four years of working for the foundation, I have come to know a great many patients, family members, caregivers, doctors, and researchers. The personal connections made with each and every person are an inspiration. To me, my work at the foundation is not just a job anymore; it’s a mission to find a cure.
Laran Hyder, Development & Events Coordinator, NET Research Foundation
I support the Neuroendocrine Tumor Research Foundation because of its tireless efforts to improve the lives of people affected by carcinoid and neuroendocrine cancer. For many years, NETRF was an invaluable source of friendship, hope, and inspiration for my family as our mother struggled with the many challenges of NET. When she died, NETRF was there with love and support, and we will never forget the joy and positivity this organization and its wonderful community brought to our mom and to our family. We will continue to support NETRF in its efforts to support those still fighting the fight.
Andrew Snyder, NET Research Foundation Supporter
What I find most appealing about the NETRF is the focus on a single group of rare cancers and on attacking the problem by understanding its roots. For the last decade on the Board of Scientific Advisers, I’ve had the privilege of working with internationally renowned and deeply committed experts whose insights have been instrumental in shaping research and in guiding exciting new discoveries.
Ramesh Shivdasani, Board of Scientific Advisors Co-Chair
NET Research Foundation is the only organization dedicated solely to curing carcinoid cancer. For those of us searching for treatments and a sense of community, the foundation provided not only information, but understanding and support to patients and their families. We understood that we were not alone.
Sheryl Anania, NET Research Foundation Supporter
As the newest member of the team, it has been a challenge and a great learning opportunity to work for the NET Research Foundation. Re-branding the organization has given me the opportunity to connect with patients and researchers to better understand the disease from the perspective of the NET community. This is the most fulfilling position I’ve held; what started as a job has turned into a passion.
Jamie Lacroix, Director of Communication & Outreach, NET Research Foundation
Many people, if they have heard of neuroendocrine tumors (NETs) at all, believe incorrectly that they are rare, benign and have only a minor impact on the health of our population. I support the Neuroendocrine Tumor Research Foundation because of its dedicated mission to raise awareness and expand our understanding of NETs amongst the general public, regulators, industry and patients and to help fund research into this often neglected area. Through grass roots efforts like these, we will hopefully improve the diagnosis, management and long-term outcome of patients with this multidisciplinary, orphan condition.
David Metz, University of Pennsylvania NET Researcher